Previous studies have shown that CSF tau does not significantly correlate with disease duration, disease severity, DPR or disease survival in patients with other types of motor neuron disease and ALS (5, 33, 34), and our results are similar to the above studies. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.